Status History
2026-07-09
OPEN → INELIGIBLE
· This is not a funding programme — it is a news tracker article (Xtalks) listing biotech companies that have already secured venture capital rounds in 2026. There is no open application, grant, fellowship, or submission mechanism on this page. The listed entities (Serif Biomedicines, Fathom Therapeutics, CellCentric, etc.) are established biotech companies that closed private VC deals; there is nothing an independent researcher can apply to here.